Amidate

Active Ingredient(s): Etomidate
FDA Approved: * September 7, 1982
Pharm Company: * HOSPIRA
Category: Anesthetic

Etomidate[1] (USAN, INN, BAN; marketed as Amidate) is a short-acting intravenous anaesthetic agent used for the induction of general anaesthesia and sedation[2] for short procedures such as reduction of dislocated joints, tracheal intubation, cardioversion and electroconvulsive therapy. It was developed at Janssen Pharmaceutica in 1964 and was introduced as an intravenous agent in 1972 in Europe and in 1983 in the United States.[3] The most comm... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Amidate 2 mg/ml Intravenous Injection, Solution
NDC: 0404-9811
Labeler:
Henry Schein, Inc.
Amidate 2 mg/ml Intravenous Injection, Solution
NDC: 0409-6695
Labeler:
Hospira, Inc.
Amidate 2 mg/ml Intravenous Injection, Solution
NDC: 0409-8060
Labeler:
Hospira, Inc.
Amidate 2 mg/ml Intravenous Injection, Solution
NDC: 0409-8061
Labeler:
Hospira, Inc.
Amidate 2 mg/ml Intravenous Injection, Solution
NDC: 0409-8062
Labeler:
Hospira, Inc.
Amidate 2 mg/ml Intravenous Injection, Solution
NDC: 52584-060
Labeler:
General Injectables and Vaccines, Inc.
Amidate 2 mg/ml Intravenous Injection, Solution
NDC: 52584-695
Labeler:
General Injectables & Vaccines, Inc